The Wistar Institute oversees one of the most prestigious
melanoma research programs in the country.
Results of the international trial, led by principal investigator Jeffrey S. Weber, MD, PhD, the Laura and Isaac Perlmutter Professor of Oncology, deputy director of Perlmutter Cancer Center, and co-leader of
its Melanoma Research Program, were published in November 2017 in The New England Journal of Medicine.
«We saw the success of
the melanoma research program and asked ourselves, «Is there something else we can do for other diseases?»»
Not exact matches
Joining forces with dermatologists and oncologists from the University Hospital in Zurich and backed by the University
Research Priority
Program «Translational Cancer
Research,» Sommer's team was able to demonstrate that, in
melanoma cells, the epigenetic factor EZH2 controls genes that govern tumor growth as well as genes that are important for the formation of metastases.
«Our findings point to two potential impacts from additional
research — analyzing the diversity and composition of the microbiome to predict response to immunotherapy and modulating the gut microbiome to enhance treatment,» said Wargo, senior researcher on the project and co-leader of the
Melanoma Moon Shot ™, part of MD Anderson's Moon Shots
Program ™ to reduce cancer deaths by accelerating development of therapies from scientific discoveries.
Caspar Wistar Professor in
Melanoma Research Director, The Wistar Institute
Melanoma Research Center Professor, Molecular and Cellular Oncogenesis
Program
Ira Brind Professor Professor and Co-
Program Leader, Immunology, Microenvironment and Metastasis
Program Member, The Wistar Institute
Melanoma Research Center
Assistant Professor, Molecular and Cellular Oncogenesis
Program Member, The Wistar Institute
Melanoma Research Center
Caspar Wistar Professor in
Melanoma Research Director, The Wistar Institute
Melanoma Research Center Professor, Molecular & Cellular Oncogenesis
Program
The main focus of my
research program is on design and preclinical evaluation of novel therapeutic strategies for treatment of metastatic cancers, including breast cancer and
melanoma.
Assistant Professor, Molecular & Cellular Oncogenesis
Program Member, The Wistar Institute
Melanoma Research Center
As part of a nationally recognized cancer
research and treatment center, the
Melanoma / Skin Cancer Program conducts innovative research to understand how melanoma develops, and how to better prevent and t
Melanoma / Skin Cancer
Program conducts innovative
research to understand how
melanoma develops, and how to better prevent and t
melanoma develops, and how to better prevent and treat it.
The
Melanoma / Skin Cancer
Program provides expert diagnosis and staging using advanced imaging technologies and
research - based molecular testing including: